ZA200900902B - Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecy L)-1,4-benzoquinone - Google Patents
Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecy L)-1,4-benzoquinoneInfo
- Publication number
- ZA200900902B ZA200900902B ZA200900902A ZA200900902A ZA200900902B ZA 200900902 B ZA200900902 B ZA 200900902B ZA 200900902 A ZA200900902 A ZA 200900902A ZA 200900902 A ZA200900902 A ZA 200900902A ZA 200900902 B ZA200900902 B ZA 200900902B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydroxydecy
- benzoquinone
- dimethoxy
- methyl
- transmucosal administration
- Prior art date
Links
- JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06016935A EP1891946A1 (en) | 2006-08-14 | 2006-08-14 | Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900902B true ZA200900902B (en) | 2010-07-28 |
Family
ID=37564291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900902A ZA200900902B (en) | 2006-08-14 | 2009-02-06 | Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecy L)-1,4-benzoquinone |
Country Status (19)
Country | Link |
---|---|
US (1) | US20090208425A1 (xx) |
EP (2) | EP1891946A1 (xx) |
JP (2) | JP5665167B2 (xx) |
CN (1) | CN101541317B (xx) |
AU (1) | AU2007286491B2 (xx) |
BR (1) | BRPI0715901A2 (xx) |
CA (1) | CA2660577C (xx) |
CY (1) | CY1117860T1 (xx) |
ES (1) | ES2574087T3 (xx) |
HU (1) | HUE029241T2 (xx) |
IL (1) | IL196745A (xx) |
MX (1) | MX2009001674A (xx) |
NZ (1) | NZ574422A (xx) |
PL (1) | PL2051706T3 (xx) |
PT (1) | PT2051706T (xx) |
RU (1) | RU2429830C2 (xx) |
SI (1) | SI2051706T1 (xx) |
WO (1) | WO2008019769A1 (xx) |
ZA (1) | ZA200900902B (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2108366B1 (en) | 2008-04-09 | 2011-10-19 | Santhera Pharmaceuticals (Schweiz) AG | Idebenone for the treatment of respiratory illness in muscular dystrophy |
EP2246048A1 (en) | 2009-04-30 | 2010-11-03 | Santhera Pharmaceuticals (Schweiz) AG | Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis |
WO2012022468A2 (en) | 2010-08-16 | 2012-02-23 | Santhera Pharmaceuticals (Schweiz) Ag | Benzoquinone derivatives as modulators of mitchondrial function |
CN102091038B (zh) * | 2011-01-20 | 2012-07-25 | 天津大学 | 艾地苯醌纳米脂质载体透皮吸收制剂及制备方法 |
US10806703B2 (en) * | 2012-01-20 | 2020-10-20 | Lts Lohmann Therapie-System Ag | Transmucosal administration system for a pharmaceutical drug |
EP2620141A1 (en) | 2012-01-25 | 2013-07-31 | Santhera Pharmaceuticals (Schweiz) AG | Thin film drug delivery system for the transmucosal administration of a 1,4-benzoquinone derivative |
US9750705B2 (en) | 2012-08-31 | 2017-09-05 | The Regents Of The University Of California | Agents useful for treating obesity, diabetes and related disorders |
US20150150790A1 (en) * | 2013-12-04 | 2015-06-04 | Jao Hung Biotechnology Co., Ltd. | Transdermal enhancer |
DE102017104277A1 (de) | 2017-03-01 | 2018-09-06 | Lts Lohmann Therapie-Systeme Ag | Transmukosales Verabreichungssystem für Idebenon |
WO2021186061A1 (en) | 2020-03-19 | 2021-09-23 | Bemido Sa | Idebenone for the treatment of acute respiratory distress syndrome (ards) in patients diagnosed with a coronavirus infection |
WO2022258629A1 (en) | 2021-06-07 | 2022-12-15 | Katholieke Universiteit Leuven | Idebenone in the treatment of drug resistant epilepsy |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2503571B2 (ja) * | 1988-02-26 | 1996-06-05 | 武田薬品工業株式会社 | 脳循環代謝改善剤 |
JPH07103018B2 (ja) * | 1988-09-16 | 1995-11-08 | 武田薬品工業株式会社 | 精神分裂病治療剤 |
JP3069458B2 (ja) * | 1992-01-29 | 2000-07-24 | 武田薬品工業株式会社 | 口腔内崩壊型錠剤およびその製造法 |
CA2252519A1 (en) * | 1996-07-11 | 1998-01-22 | Keisuke Hirai | Use of idebenone and analogues against beta amyloid induced cytotoxicity |
JPH11116470A (ja) * | 1997-08-12 | 1999-04-27 | Takeda Chem Ind Ltd | イデベノン含有経皮投与製剤 |
EP1021204B1 (en) * | 1997-09-26 | 2005-12-28 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
CA2272971C (en) * | 1998-10-29 | 2008-01-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Quinone derivatives for treating or preventing diseases associated with iron overload |
SE9803760D0 (sv) * | 1998-11-04 | 1998-11-04 | Jan Hedner | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel |
AU6730400A (en) * | 1999-08-26 | 2001-03-26 | Takeda Chemical Industries Ltd. | Matrix adhering to nasal mucosa |
JP2003026567A (ja) * | 2001-05-10 | 2003-01-29 | Kanegafuchi Chem Ind Co Ltd | 補酵素qを有効成分とする粘膜投与用組成物 |
DE60211875T2 (de) * | 2002-07-01 | 2006-10-26 | Santhera Pharmaceuticals (Schweiz) Ag | Screeningverfahren und Verbindungen zur Behandlung von Friedreich ataxia |
US20040067986A1 (en) * | 2002-10-04 | 2004-04-08 | Nathan Sassover | Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer |
EP1618881A1 (en) * | 2004-07-20 | 2006-01-25 | Santhera Pharmaceuticals (Schweiz) GmbH | Use of non-glucocorticoid steroids for the treatment of muscular dystrophy |
RU2357758C2 (ru) * | 2004-10-07 | 2009-06-10 | Кабусики Кайся Санги | Препараты для чрескожной и чресслизистой доставки |
US7977388B2 (en) * | 2005-03-21 | 2011-07-12 | Santhera Pharmaceuticals (Schweiz) Ag | Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of muscular dystrophies |
-
2006
- 2006-08-14 EP EP06016935A patent/EP1891946A1/en not_active Withdrawn
-
2007
- 2007-08-03 WO PCT/EP2007/006895 patent/WO2008019769A1/en active Application Filing
- 2007-08-03 PT PT78015112T patent/PT2051706T/pt unknown
- 2007-08-03 NZ NZ574422A patent/NZ574422A/en not_active IP Right Cessation
- 2007-08-03 EP EP07801511.2A patent/EP2051706B1/en active Active
- 2007-08-03 MX MX2009001674A patent/MX2009001674A/es active IP Right Grant
- 2007-08-03 JP JP2009524098A patent/JP5665167B2/ja active Active
- 2007-08-03 CN CN200780030147.3A patent/CN101541317B/zh active Active
- 2007-08-03 CA CA2660577A patent/CA2660577C/en active Active
- 2007-08-03 RU RU2009103638/15A patent/RU2429830C2/ru active
- 2007-08-03 AU AU2007286491A patent/AU2007286491B2/en not_active Ceased
- 2007-08-03 BR BRPI0715901-3A patent/BRPI0715901A2/pt not_active Application Discontinuation
- 2007-08-03 ES ES07801511.2T patent/ES2574087T3/es active Active
- 2007-08-03 PL PL07801511.2T patent/PL2051706T3/pl unknown
- 2007-08-03 SI SI200731778A patent/SI2051706T1/sl unknown
- 2007-08-03 HU HUE07801511A patent/HUE029241T2/en unknown
- 2007-08-03 US US12/375,586 patent/US20090208425A1/en not_active Abandoned
-
2009
- 2009-01-27 IL IL196745A patent/IL196745A/en active IP Right Grant
- 2009-02-06 ZA ZA200900902A patent/ZA200900902B/xx unknown
-
2013
- 2013-01-11 JP JP2013003311A patent/JP5907901B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-27 CY CY20161100744T patent/CY1117860T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN101541317B (zh) | 2015-04-15 |
JP2013100319A (ja) | 2013-05-23 |
HUE029241T2 (en) | 2017-02-28 |
CN101541317A (zh) | 2009-09-23 |
PT2051706T (pt) | 2016-07-18 |
EP1891946A1 (en) | 2008-02-27 |
JP5907901B2 (ja) | 2016-04-26 |
WO2008019769A1 (en) | 2008-02-21 |
EP2051706B1 (en) | 2016-05-11 |
IL196745A0 (en) | 2009-11-18 |
AU2007286491B2 (en) | 2010-06-24 |
NZ574422A (en) | 2011-04-29 |
RU2009103638A (ru) | 2010-09-27 |
BRPI0715901A2 (pt) | 2013-08-06 |
CY1117860T1 (el) | 2017-05-17 |
AU2007286491A1 (en) | 2008-02-21 |
MX2009001674A (es) | 2009-02-25 |
SI2051706T1 (sl) | 2016-06-30 |
JP2010500384A (ja) | 2010-01-07 |
RU2429830C2 (ru) | 2011-09-27 |
JP5665167B2 (ja) | 2015-02-04 |
IL196745A (en) | 2016-10-31 |
CA2660577A1 (en) | 2008-02-21 |
EP2051706A1 (en) | 2009-04-29 |
ES2574087T3 (es) | 2016-06-14 |
PL2051706T3 (pl) | 2016-11-30 |
CA2660577C (en) | 2012-05-01 |
US20090208425A1 (en) | 2009-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200900902B (en) | Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecy L)-1,4-benzoquinone | |
IL198753A0 (en) | Oral transmucosal nicotine dosage form | |
GB0508306D0 (en) | Nicotine dosage forms | |
IL201973A0 (en) | 3,3-spiroindolinone derivatives | |
IL206765A0 (en) | 4,5-dihydro-oxazol-2-yl-amine derivatives | |
DOP2007000080A (es) | Piridin [3,4-b] pirazinonas | |
EP2222659A4 (en) | INDOLE, DERIVATIVES AND ANALOGUE THEREOF AND APPLICATIONS THEREOF | |
ZA200810683B (en) | C-phenyl 1-thioglucitol compound | |
HK1137990A1 (en) | Thienyl-containing glycopyranosyl derivatives as antidiabetics | |
ZA201001797B (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
EP2014626A4 (en) | SEMICONDUCTOR CERAMIC COMPOSITION | |
IL199014A0 (en) | 4-hydroxy-2-oxo-2,3-dihydro-1,3- | |
IL176630A0 (en) | Benzimidazole derivatives | |
EP1941896A4 (en) | COMPOSITION CONTAINING A DIPEPTIDE FOR ORAL ADMINISTRATION | |
HK1122218A1 (en) | Anticancer concomitant drug | |
IL193475A0 (en) | Benzimidazole derivatives | |
IL197883A0 (en) | Combination drug | |
EP2074647A4 (en) | FORMATION OF INTERCONNECTION HOLES IN SLICES | |
EP2022454A4 (en) | WHEELCHAIR | |
TWI373136B (en) | Multiple-transistor semiconductor structure | |
IL196200A0 (en) | Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy)phenoxathin-10,10-dioxide | |
EP2060563A4 (en) | CYCLIC AMINOALKYLCARBOXAMIDE DERIVATIVE | |
PL2099765T3 (pl) | 5-, 6- lub 7-podstawione pochodne 3-aryloizochinolinoaminy jako środki przeciwnowotworowe | |
EP2158908A4 (en) | COMPOSITION FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION | |
GB0702895D0 (en) | Delta 9 tetrahydrocannabinol derivatives |